Trial intelligence / Profile preview

Amnion Graft for Preventing Intrauterine Adhesions

NCT02132104Unknown

Sponsor
Capital Medical University
Start
Nov 2014
Primary completion
Aug 2016
Countries
1
01

Overview

Randomised, open-label trial (2 arms), sponsored by Capital Medical University. Primary endpoint: Safety of intrauterine application of amnion membrane at 3 months. Status: unknown.

Beyond the preview

Go deeper on NCT02132104.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02132104.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call